David S. Utterberg is Director at NxStage Medical, Inc. (NXTM). They have made 2 open-market trades across 1 company since 2010, most recently 2013-01-03.
CIK 0001341407
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NXTM | 3,893,818 | $116.8M |
Shares reported on the most recent Form 4, priced at the 2013-01-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NXTM | SELL · 10b5-1 | 2013-01-03 | 2013-01-03 | $11.14 | $120K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2012-12-31 | 2013-01-02 | $11.25 | $407K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2012-12-20 | 2012-12-21 | $11.05 | $163K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2012-12-17 | 2012-12-19 | $11.26 | $578K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2012-12-12 | 2012-12-14 | $11.20 | $571K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2012-12-07 | 2012-12-11 | $11.32 | $693K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2012-12-04 | 2012-12-06 | $11.20 | $1.5M | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2012-11-29 | 2012-12-03 | $12.06 | $816K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2012-11-26 | 2012-11-28 | $11.71 | $724K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2012-11-21 | 2012-11-26 | $11.65 | $322K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2012-11-19 | 2012-11-21 | $11.22 | $309K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2012-11-14 | 2012-11-16 | $11.29 | $417K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2012-11-08 | 2012-11-13 | $11.58 | $2.1M | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2012-11-05 | 2012-11-07 | $11.07 | $80K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2012-10-31 | 2012-11-02 | $11.13 | $387K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2012-10-26 | 2012-10-30 | $11.22 | $121K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2012-10-24 | 2012-10-26 | $11.28 | $696K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2012-10-19 | 2012-10-23 | $11.51 | $1.0M | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2012-10-16 | 2012-10-18 | $12.28 | $635K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2011-06-29 | 2011-07-01 | $20.46 | $2.0M | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2011-06-24 | 2011-06-28 | $20.26 | $2.8M | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2011-06-22 | 2011-06-24 | $20.11 | $1.5M | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2011-06-17 | 2011-06-21 | $19.74 | $1.8M | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2011-06-15 | 2011-06-17 | $19.32 | $616K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2011-06-13 | 2011-06-15 | $19.22 | $769K | -11.6% | -2.1% | -2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.